Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Blank Controlled, Multicenter Clinical Trial of the Effection of Potassium Citrate Extended-release Tablets on Urolithiasis Formation or Recurrence

NCT03007160 is registered in ClinicalTrials.gov with Dawnrays Pharmaceutical (Holdings) Limited as lead sponsor.

NCT NCT03007160
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03007160 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Blank Controlled, Multicenter Clinical Trial of the Effection of Potassium Citrate Extended-release Tablets on Urolithiasis Formation or Recurrence
Lead sponsor
Dawnrays Pharmaceutical (Holdings) Limited
Phase
Phase 4
Overall status
Unknown status
Start date
July 31, 2016
Completion date
September 30, 2020
Enrollment
2,001 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

urolithiasis